Emma Reeve is a global finance executive who has worked in healthcare for over 20 years across pharmaceutical, medical device and bio-pharma companies. Prior to joining Constellation Pharmaceuticals, Emma served as interim chief financial officer and corporate controller of PAREXEL International, where she was responsible for all aspects of financial reporting and accounting, investor relations, financial planning and analysis. Previously, Emma held senior finance roles at major pharma companies including Novartis, Merck and Bristol-Myers Squibb. She was also the chief financial officer of two development-stage biotech companies, Inotek Pharmaceuticals and Aton Pharma. In addition to finance, Emma has held senior positions in a number of countries in areas such as marketing, supply chain management and research operations. Emma holds a B.Sc. in computer science from Imperial College, University of London and is an associate of the Institute of Chartered Accountants in England & Wales.